A Russian company is preparing to launch clinical trials of a peptide vaccine against cancer in 2027
⚡ Quick Summary
The Russian pharmaceutical company Promomed announced its plans to begin in 2027 the first phase of clinical trials for a new peptide anti-cancer vaccine.
🗞️ 1 sources covered this story
📰 Related Articles
Macron responds firmly to Trump's threat to impose tariffs on French wine and champagne
RT عربي
مشاهدات نادرة للقرش الأزرق في تونس.. وخبراء يوضحون الأسباب
RT عربي
Said Bennis: Civil behavior in Morocco is a reflection of citizenship and a soft power that needs educational and societal consolidation
اليوم 24
New details regarding procedures for settling taxes and clearing tax dues
الشروق